Vanguard Personalized Indexing Management LLC Has $1.04 Million Holdings in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Vanguard Personalized Indexing Management LLC increased its holdings in DENTSPLY SIRONA Inc. by 189.4%, now owning 65,315 shares valued at approximately $1.04 million.
• Institutional investors dominate DENTSPLY SIRONA's stock ownership, holding about 95.70% of shares, indicating strong institutional interest.
• The company's stock has experienced a price range in the past year, with a low of $11.69 and a high of $24.86, currently trading around $12.51.

Vanguard Personalized Indexing Management LLC boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 189.4% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 65,315 shares of the medical instruments supplier's stock after buying an additional 42,747 shares during the quarter. Vanguard Personalized Indexing Management LLC's holdings in DENTSPLY SIRONA were worth $1,037,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. acquired a new stake in DENTSPLY SIRONA in the first quarter valued at about $25,000. Trust Co. of Toledo NA OH bought a new position in DENTSPLY SIRONA in the second quarter valued at about $27,000. Brooklyn Investment Group bought a new position in DENTSPLY SIRONA in the first quarter valued at about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in DENTSPLY SIRONA in the first quarter valued at about $26,000. Finally, Caitong International Asset Management Co. Ltd raised its position in DENTSPLY SIRONA by 8,003.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier's stock valued at $34,000 after purchasing an additional 2,241 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have commented on XRAY shares. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Barrington Research dropped their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research report on Friday, August 8th. Wall Street Zen downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday. Weiss Ratings reiterated a "sell (d-)" rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company dropped their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $18.00.

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $12.51 on Friday. DENTSPLY SIRONA Inc. has a 1 year low of $11.69 and a 1 year high of $24.86. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company has a market capitalization of $2.50 billion, a price-to-earnings ratio of -2.64, a price-to-earnings-growth ratio of 0.78 and a beta of 0.96. The business has a 50-day moving average of $13.38 and a 200-day moving average of $14.51.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same period last year, the company earned $0.49 earnings per share. The firm's revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 5.1%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -13.50%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.